# PolyTreg Immunotherapy in Islet Transplantation

> **NCT03444064** · PHASE1 · COMPLETED · sponsor: **University of Alberta** · enrollment: 11 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **BIOLOGICAL:** PolyTregs

## Key facts

- **NCT ID:** NCT03444064
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2024-08-12
- **Final completion:** 2024-12-17
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03444064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03444064, "PolyTreg Immunotherapy in Islet Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03444064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*